ABSTRACT-The effects of menatetrenone (2-methyl-3-tetraprenyl-1,4-naphthoquinone, MK-4) on cal cium balance were studied in male Sprague-Dawley rats. Experiment 1: Rats in metabolic cages that were fed a vitamin K-deficient diet and injected daily with latamoxef (100 mg/kg, i.p.) were either treated or untreated with MK-4 for 7 days. Daily food intake, urine volume and feces weight were determined, and calcium concentration in these samples was measured. Calcium balance was calculated as the difference between calcium intake and urinary and fecal calcium excretion. Cumulative calcium balance in the vitamin K-deficient group treated with latamoxef was lower than that in normal rats; this balance was significantly improved by MK-4 (1 and 10 mg/kg, s.c.) administered for 7 days. Experiment 2: Rats were fed a vitamin K-deficient diet containing 4.6°1o sodium chloride for 6 weeks. MK-4 was administered as a dietary supple ment. Forty-eight-hour calcium balance, determined once a week, was significantly reduced compared with that of normal rats after 3 and 5 weeks; the balance was restored dose-dependently by MK-4 administration (1 and 10 mg/kg). Experiment 3: Rats were subjected to the same experimental conditions as experiment 2 for 6 weeks, and intestinal calcium transport was determined using an everted gut-sac technique. Calcium transport was reduced by the high sodium, vitamin K-deficient diet, and this reduction was restored by MK 4 administration (10 mg/kg). These results suggest that MK-4 improves the reduced calcium balance by increasing intestinal calcium absorption in these rats.
Since Bouckaert and Said, in 1960 , reported that vita min K accelerates the rate of bone fracture healing in rab bits and rats (1) , interest has focused on the role played by vitamin K in bone metabolism. Circulating levels of vita min K in osteoporotic patients have been shown to be significantly lower than those in age-matched control subjects (2) . The use of a coumarin-related vitamin K an tagonist during pregnancy was found to cause character istic nasal hypoplasia or stippled epiphysis (3) . A vitamin K2 homologue, menatetrenone (MK-4), was shown to be effective in ameliorating bone loss induced by ovari ectomy in rats (4) , and the clinical efficacy of MK-4 was demonstrated in a double-blind multi-center comparative study with alfacalcidol in patients with postmenopausal and senile osteoporosis (5) . Vitamin K, prevented in creases in urinary calcium excretion in rats that received vitamin K-deficient feed and antibiotics (6) and in postmenopausal women (7) . Depressed levels of menaqui nones were also shown to induce fractures in osteoporotic patients (8) . These results suggest that vitamin K is related to calcium balance and that it ameliorates bone loss. This study was carried out to elucidate the effect of a vitamin K2 homologue, MK-4, on calcium balance.
The effects of this agent on calcium balance and absorp tion were evaluated under two experimental conditions: rats fed a vitamin K-deficient diet combined with anti biotic administration (Experiment 1), and rats fed a high sodium, vitamin K-deficient diet (Experiments 2 and 3). Antibiotic administration has been shown to produce a vitamin K-deficient state in rats (9) , and sodium chloride loading has been shown to induce hypercalciuria (10) . We observed changes in calcium balance in these models and examined the ameliorative effects of MK-4 on calcium balance and absorption.
MATERIALS AND METHODS

Animals
Prior to the experiment, the animals were housed in a room maintained at 25 ± 2 C with a 12 hr light-dark cycle and were allowed free access to a conventional feed and distilled water.
Experiment 1 (Antibiotic administered model) Twenty-four male Sprague-Dawley (SD; Japan SLC, Inc., Shizuoka) 7-week-old rats were used. The animals were assigned to four groups: normal, control, MK-4 at 1 mg/kg/day and MK-4 at 10 mg/kg/day groups. All rats were then kept individually in metabolic cages with free access to food and water for 7 days. The normal group was given a normal diet (Clea Japan Inc., Tokyo). The control and MK-4 groups were given a vitamin K deficient diet (Clea Japan Inc.) and daily intraperitoneal injection of 100 mg/kg of latamoxef (Shiomarin® injec tion; Shionogi & Co., Ltd., Osaka). The MK-4 groups were given Kaytwo® injection (Eisai Co., Ltd., Tokyo) at the dose of 1 mg/kg or 10 mg/kg, subcutaneously, once a day for 7 days. The control group received an equivalent volume of saline solution. Food intake, urine volume, and feces weight were determined every day. On day 7, animals were put under ether anesthesia, and blood was drawn from the abdominal aorta.
Experiment 2 (Sodium-loaded model)
Thirty-two male SD 6-week-old rats (Charles River Japan Inc., Tokyo) were used. The animals were assigned to four groups: normal, control, MK-4 at 1 mg/kg and MK-4 at 10 mg/kg groups. All rats were allowed free ac cess to food and water for 6 weeks. The normal group was given a normal diet. The control group was given a vitamin K-deficient diet containing 4.6% sodium chloride (Clea Japan Inc.). MK-4 groups were given a diet contain ing 2 mg or 20 mg MK-4 per 100 g vitamin K-deficient diet with 4.6% sodium chloride (Clea Japan Inc.). All these rats were put into individual metabolic cages for 48 hr once a week for the determination of food and drinking water intake, and collection of urine and feces. After urine was collected at the end of the 6-week period, blood was collected as in experiment 1, and the kidneys and femurs were then removed.
Experiment 3 (Intestinal calcium transport)
Forty-eight male SD 5-week-old rats (Charles River Japan Inc.) were used. The animals were assigned to four groups: normal, control, MK-4 at 10 mg/kg and la-OH D3 groups. The normal group was given a normal diet. The control group was given a vitamin K-deficient diet containing 4.6% sodium chloride. The MK-4 group received a vitamin K-deficient and sodium-loaded diet containing 20 mg MK-4 per 100 g diet. The 1 a-OH-D3 group was given a vitamin K-deficient diet containing 4.6% sodium chloride and injected with 1 pg/kg la-OH D3 (Onealfa® solution; Teijin Co., Ltd., Osaka) intra peritoneally every other day for 6 days before they were sacrificed. Intestines were isolated after 6 weeks of treat ment under ether anesthesia.
Analytical method
Anticoagulant activity was measured as the coagulation time determined by a Hepaplastin® test (Eisai Co., Ltd.) using citrated plasma. Serum calcium was determined with a calcium counter (CA-202; Hiranuma Co., Ltd., Tokyo). Serum inorganic phosphorus was determined by a phosphate-molybdic acid method (11) . Alkaline phos phatase activity was determined by the Bessey-Lowry method (12) . Creatinine was determined by the Folin-Wu method (13) . Urea nitrogen was determined by a urease method (BUN-EN reagent; Kinos Laboratories, Inc., Tokyo). Urine was collected in a reservoir in which toluene had been placed beforehand as an antiseptic. The collected urine, adjusted to pH 3 with 6 M hydrochloric acid, was then centrifuged. The upper layer was used as the urine sample. Feces dried for 5 days in a desiccator under reduced pressure with silica gel was weighed. The entire amount of the dried feces was then pulverized. A portion of the powdered feces was weighed and ashed, and the product dissolved in 0.1 M hydrochloric acid. Calcium content was then determined. Calcium in the diet was determined by the method noted above. Urinary cal cium and creatinine were measured by the same methods as for the serum. Urinary sodium was determined with a flame photometer (775A; Hitachi Co., Ltd., Tokyo). MK-4 levels in the serum and diet were determined by an HPLC-fluorometer (14) . Calcium balance was calculated by the difference be tween calcium intake and total calcium excretion in urine and feces. Cumulative calcium balance in experiment 1 was determined daily from day 1, when the conventional diet was changed to the experimental diet, to day 7. In experiment 2, calcium balance was determined for 2 days per week when the animals were in metabolic cages, and the value was then extrapolated for the whole week. Cumulative weekly level was determined for 6 weeks. Because the body weights of animals in the experimental groups were all less than those in the normal group, we expressed the parameters of renal function and calcium balance as the level per 100 g body weight.
The right femur was removed and dissected from the ad hering connective tissues and muscles, washed with ether and acetone, and dried and weighed. The volume of bone was determined according to Archimedes' principle. A container filled with water was weighed. The bone was sus pended with a thin wire and completely immersed in the water, taking care not to allow it to touch the beaker. Af ter removing the bone, the container was weighed again. The difference between the two weights divided by the den sity of water (1 g/ml) gave the volume of the bone. Bone density was calculated as the ratio of the weight to the volume of bone.
Intestinal calcium transport was determined by the everted gut-sac technique (15) . Rats were fasted for 16 hr before use. Under ether anesthesia, blood was drawn from the abdominal aorta and small intestines were removed. These intestines were immediately rinsed by saline, and the first 10 cm of the intestine distal to the pyloric valve was dissected. Much of the mesentery was trimmed free, and the intestine was everted in a manner such that the distal end of the segment remained tied to the everting rod. The intestine was then tied with a liga ture just distal to the pyloric valve. It was then blotted, trimmed to a length of 4.0 cm, and filled with 0.4 ml of in cubation medium using a syringe fitted with a blunt nee dle. The incubation medium consisted of 125 mM NaCl, 10 mM fructose, 30 mM Tris-HCl, and 0.25 mM CaC12 2H20. The sac was then placed in a 25 ml Erlenmeyer flask containing 10 ml of the same incubation medium and incubated at 371C for 60 min. A gas mixture (9501o 02, 5010 C02) was continuously bubbled through the incuba tion medium, and the flask was shaken at 60 times/min. After 60 min, the sac was removed from the flask, and most of the external liquid was allowed to drip off. After the final drop was carefully blotted away, the sac was cut, and the content was drained from the pyloric end into a centrifuging tube. The calcium concentration of the fluid inside and outside of the sac was determined by the OCPC method (o-cresolphthalein complexone) (Calcium C test Wako; Wako Pure Chem. Ind., Osaka). Intestinal calcium transport was expressed as the ratio (S/M) of the calcium concentration in the serosal medium (inside the sac) to that in the mucosal medium (outside). Serum 1,25(OH)2D3 level was determined by a radio-receptor as say (16) . In both the normal and MK-4 groups, one intes tine was excluded from the experiment because prepara tion of the gut-sac was unsuccessful.
Statistical analyses
The data shown in the tables and figures are expressed as the means±standard error of the means (S.E.M.). Statistical significance of the difference between the nor mal group and control group was analyzed by Student's t-test. Statistical significance of the difference between the control and MK-4 groups was assessed by two-way analy sis of variance followed by Dunnett's test; P values below 0.05 were regarded as significant. The difference in cal cium balance between the control and MK-4 groups was analyzed by the one-way method, because the variance in both groups occurred in only one direction in experiments 1 and 2. 
RESULTS
Experiment 1 (Antibiotic administration model)
Coagulation activity and renal function on day 7 are shown in Table 1 . The blood coagulation time in the con trol group was significantly prolonged (P<0.01) com pared with that in the normal group, but the values for the MK-4 groups remained similar to that for the normal group. Although urinary sodium excretion was lower in the control group than in the normal group, the glomeru lar filtration rate and serum urea nitrogen values were similar in all four groups. Table 2 shows the serum calcium and alkaline phos phatase activity on day 7. The serum calcium level was almost the same for all groups, while the MK-4 at 10 mg/kg group had significantly lower serum alkaline phos phatase activity than the control group (P <0.05). Table 3 shows the calcium intake, urinary and fecal calcium excre tion, and calcium balance. The calcium intake was sig nificantly lower in the control group than the normal The cumulative calcium balance is shown in Fig. 1 . The balance in the control group increased almost in parallel to that in the normal group. Although the calcium balance in the MK-4 groups was reduced on day 1 to the level of the control group, it gradually approached the level of the normal group. On day 7, the calcium balance in the MK-4 at 1 mg/kg group had improved, but not sig nificantly, while that in the MK-4 at 10 mg/kg group was significantly improved (P < 0.05).
Experiment 2 (Sodium-loaded model)
The mean daily doses in the 1 and 10 mg/kg MK-4 groups over the 6-week period were 1.28 and 14.68 mg/kg, respectively. High serum MK-4 concentrations were attained in rats given MK-4 for 6 weeks, and the level was dose-dependent ( Table 4 ). The serum MK-4 con centration in the control group was 47% of that in the normal group; but the blood coagulation time in the con trol group was not prolonged. Table 5 shows the urine volume, urinary sodium excretion and renal function. The urine volume in the control group was twice that in the normal group, and that in the MK-4 groups was almost the same as in the control group. Urinary sodium excretion in the control group was 7.4-fold higher than that in the normal group and similar to that in the MK-4
groups. The glomerular filtration rate and serum urea nitrogen values in all the sodium-loaded groups were the same as those in the normal group. Table 6 shows the changes in calcium intake, urinary and fecal calcium excretion and calcium balance during the experimental period. The calcium intake and urinary and fecal calcium excretion values in the normal group were highest at the beginning of the experiment, then decreased gradually. Compared with the normal group, the control group showed significantly lower calcium intake on day 2, higher urinary calcium excretion from day 2 to 6 weeks and higher fecal calcium excretion at 5 weeks. Compared with the control group, the calcium in take in both MK-4 groups was lower at 5 weeks, the fecal calcium excretion in the MK-4 at 1 mg/kg group was sig nificantly lower at 5 weeks and that of the MK-4 at 10 mg/kg group was significantly lower from 3 to 6 weeks. The calcium balance in the normal group showed a high value on day 2, then decreased gradually. The calcium balance in the control group was lower than that in the normal group throughout the experimental period with significant differences (P < 0.05) at 3 and 5 weeks, whereas both MK-4 groups had higher calcium balance than the control group at 3 to 5 weeks. The effect of MK-4 was dose-dependent. The cumulative calcium balance in the control group increased to the same extent as the normal group for 2 weeks (Fig. 2) . From 3 weeks on, the increase in the control group slowed down, and the value was sig nificantly lower than the normal group at 5 weeks. The cumulative calcium balance in the MK-4 groups increased gradually, showing higher values than the control group at 3 weeks and later. The curve for the MK-4 at 1 mg/kg group was similar to that of the normal group. In the MK-4 at 10 mg/kg group, significantly higher values than the control were observed at 3 to 5 weeks. Serum calcium and inorganic phosphorus concentra tions determined at 6 weeks were almost the same in all the experimental groups, but serum alkaline phosphatase activity in the control group was significantly lower than that in the normal group (Table 7) . To evaluate whether the reduction of calcium balance influences the bone mass, the bone parameters were determined ( Table 8) . The volume and length of the femur were almost the same among the groups. No significant differences was ob served in the dry weight and bone density of femurs be tween the normal and control groups, but sodium loading for 6 weeks tended to decrease the bone density (P < 0.10). 
Experiment 3 (Intestinal calcium transport)
The mean doses of MK-4 during this experiment was 14.68 mg/kg/day, calculated from the body weight and food intake. After 6 weeks of treatment, the body weight of the sodium loading groups was lower than that of the normal group, but the difference was not significant (data not shown). The result of intestinal calcium transport is shown in Fig. 3 . Vitamin K deficiency and sodium loading resulted in a significant decrease in the S/M ratio com pared with the normal group (P<0.05). The S/M ratio in the MK-4-treated group was higher than that in the con trol group and was restored to the normal level, and that in la-OH-D3 treated group was almost the same as the MK-4-treated group. Serum 1,25(OH)2D3 levels in the nor mal, control and MK-4-treated groups were 50.4±6.2, 54.6±5.6 and 45.1::L-5.1 pg/ml, respectively, and there were no differences among these three groups.
DISCUSSION
Primary vitamin K deficiency is a rare occurrence even in animals receiving a vitamin K-deficient diet, since vita min K is produced by the intestinal flora (17) . We have already reported that a vitamin K-deficient state is pro duced in rats that receive antibiotics and that the degree of enhancement of this state depends on the type of anti biotic used (9). Robert et al. (6) reported that rats given a vitamin K-deficient diet and antibiotics simultaneously exhibited a prolonged blood coagulation time and in creased cumulative urinary calcium excretion, but no change in calcium balance. These changes were amelio rated by vitamin K, supplementation.
In their study, tobramycin, vancomycin and colimycin were administer ed as additives in the drinking water. Tobramycin is an aminoglycoside derivative that has potent renal toxicity (18) , and this toxicity is potentiated in combination with vancomycin (19) . It has been shown recently that tobra mycin inhibits Na,Ca-ATPase and accelerates urinary cal cium excretion (20) . Thus, tobramycin might have con tributed to the increased urinary calcium excretion in the study by Robert et al. (6) . In this study, we administered the antibiotic latamoxef intraperitoneally to rats given a vitamin K-deficient diet. Prolongation of coagulation time and deterioration of calcium balance were observed, but there was no increase in urinary calcium excretion. Blood coagulation time was significantly prolonged (Table 1) , the degree being almost the same as that re ported by Robert et al. (6) . Despite an apparently similar state of vitamin K deficiency in the two studies, our results on calcium balance were different from those reported by Robert et al. (6) . This discrepancy may have been due to the different antibiotics used. The control group in experi ment 1 (in which animals received latamoxef) showed no change in renal function (Table 1) . However, the food intake in this group decreased from day 1, and the decreased calcium intake thus resulted in a decrease in urinary calcium excretion (Table 3 ). These results suggest that the decrease in urinary calcium excretion may have been due primarily to the decrease in food intake that oc curred with latamoxef administration, rather than to the vitamin K-deficient state. Since the change in food intake greatly affected urinary and fecal calcium excretion, we employed the calcium balance as a marker for drug evalu ation. We found that MK-4 at 10 mg/kg significantly im proved the deteriorated calcium balance caused by the vitamin K-deficient diet and administration of antibiotic. Urinary calcium excretion has been shown to increase in proportion to the degree of sodium loading when renal function is normal (10) . In this study, we also showed that the urinary calcium excretion increased notably in sodium-loaded animals by three to four-fold that of the normal group (Table 6 ). Fecal calcium excretion was little changed in these animals. Thus, the calcium balance in the control group was lower than that in the normal group. However, fecal calcium excretion was 50 to 60 times higher than urinary calcium excretion in the normal group ( Table 6 ), indicating that the calcium balance is affected to a much greater extent by fecal calcium excre tion than by urinary excretion. Therefore, changes in cal cium absorption in the intestine have a great effect on cal cium balance. In the sodium-loaded rats fed a vitamin K deficient diet, MK-4 depressed fecal calcium excretion dose-depedently and improved the calcium balance. Therefore, we investigated the intestinal calcium trans port in sodium-loaded rats fed a vitamin K-deficient diet. Sodium loading together with vitamin K-deficient diet feeding reduced intestinal calcium transport, and MK-4 lessened this reduction (Fig. 3) . These results suggest that intestinal calcium transport plays an important role in cal cium balance in sodium-loaded and vitamin K-deficient rats, and that the improvement of calcium balance by MK-4 may be partly due to the amelioration of the reduc tion in calcium transport in this model. Because no differ ences in serum 1,25(OH)2D3 level were observed among all groups tested, the action of MK-4 may not occur through the activation of vitamin D3.
We have already shown that MK-4 ameliorates bone loss induced by ovariectomy (4) and steroid administ ration (21) in rats. MK-4 has been shown to inhibit bone resorption in a mouse calvaria culture system (22) and en hance the mineralization of osteoblasts in a human cell culture system (23) . It is well known that calcium absorp tion from the intestine decreases in ovariectomized rats (24) and in rats that have been treated with steroids (25) . In this study, the reduction in calcium balance tended to induce the decrease in bone density, suggesting that cal cium balance plays an important role in bone metabo lism. The effect of MK-4 on calcium balance may con stitute a mechanism for the prevention of bone loss.
